We evaluated PAK1 activation (pPAK1/PAK1), synaptic integrity (Golgi staining), and AD‐relevant biomarkers to evaluate potential prevention of spine loss in young mice or restoration of synaptic integrity in aged mice with significant amyloid accumulation. The gene discussed is PAK1; the disease is Alzheimer disease.